Your browser doesn't support javascript.
loading
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study.
Loeff, Floris C; Tsakok, Teresa; Dijk, Lisanne; Hart, Margreet H; Duckworth, Michael; Baudry, David; Russell, Alice; Dand, Nick; van Leeuwen, Astrid; Griffiths, Christopher E M; Reynolds, Nick J; Barker, Jonathan; Burden, A David; Warren, Richard B; de Vries, Annick; Bloem, Karien; Wolbink, Gerrit Jan; Smith, Catherine H; Rispens, Theo.
Afiliación
  • Loeff FC; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands. Electronic address: F.Loeff@Sanquin.nl.
  • Tsakok T; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Dijk L; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.
  • Hart MH; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.
  • Duckworth M; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Baudry D; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Russell A; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Dand N; Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; Health Data Research UK, London, United Kingdom.
  • van Leeuwen A; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, Netherlands.
  • Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom.
  • Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Barker J; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Burden AD; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
  • Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom.
  • de Vries A; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, Netherlands.
  • Bloem K; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, Netherlands.
  • Wolbink GJ; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands; Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.
  • Smith CH; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Rispens T; Department of Immunopathology, Sanquin Research & Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.
J Invest Dermatol ; 140(11): 2129-2137, 2020 11.
Article en En | MEDLINE | ID: mdl-32283057
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Ustekinumab / Anticuerpos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Ustekinumab / Anticuerpos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2020 Tipo del documento: Article